Clinical Trial Update: Metabolic and Clinical Effect of Alpha-lipoic Acid Administration in Schizophrenic Subjects [NA]

View source ↗

Summary

A completed clinical trial evaluating the metabolic and cardiac effects of alpha-lipoic acid in people with schizophrenia; results were posted in 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Alpha Lipoic Acid (alpha-lipoic acid)

Snippet

Sponsor: University of Messina | Conditions: Metabolic Evaluation, Cardiac Complications | NA | Status: COMPLETED | Results posted: 2025-03-27